|Other Accession||NM_144719, NP_653320|
|Reactivity||Human, Horse, Bovine|
|Predicted||Human, Horse, Bovine|
|Other Names||Coiled-coil domain-containing protein 13, CCDC13 (HGNC:26358)|
|Format||Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.|
|Reconstitution & Storage||Add 50 ul of distilled water. Final anti-CCDC13 antibody concentration is 1 mg/ml in PBS buffer with 2% sucrose. For longer periods of storage, store at 20°C. Avoid repeat freeze-thaw cycles.|
|Precautions||CCDC13 Antibody - N-terminal region is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Required for primary cilia formation and promotes the localization of the ciliopathy protein BBS4 to both centriolar satellites and cilia.|
|Cellular Location||Cytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satellite Cytoplasm, cytoskeleton, cilium basal body|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Muzny D.M.,et al.Nature 440:1194-1198(2006).
Staples C.J.,et al.J. Cell Sci. 127:2910-2919(2014).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.